Search for: "Abbott Laboratories, Inc." Results 241 - 260 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2010, 2:34 pm by Phillips & Cohen
December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies.Three drug makers - Abbott Laboratories Inc., Roxane Laboratories Inc. and B. [read post]
13 Dec 2010, 1:51 pm by fraudfighters
Department of Justice announced that it has reached a settlement agreement with the pharmaceutical companies Abbott Laboratories Inc., B. [read post]
9 Dec 2010, 4:40 am by Ben Vernia
According to DOJ’s press release the company will pay $41 million and enter into a Deferred Prosecution Agreement: Kos Pharmaceuticals, a subsidiary of Abbott Laboratories, has agreed to pay more than $41 million to resolve criminal and civil liability arising from conduct relating to its drugs Advicor and Niaspan, the Justice Department announced today. [read post]
8 Dec 2010, 6:07 pm by Larry Jones
  The medications include Abbott Laboratories Inc's Lupron, AstraZeneca's Zoladex and Sanofi-Aventis SA's Eligard.According to the FDA, the drugs, known as gonadotropin-releasing hormone (GnRH) agonists, are used to suppress the production of testosterone, a hormone that helps fuel prostate cancer growth. [read post]
8 Dec 2010, 2:20 am by Marie Louise
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US: Jewish law… [read post]
6 Dec 2010, 2:36 am by Kelly
Johnson & Johnson (Kluwer) EWHC (Pat) finds no infringement of coronary stent patents: Abbott Laboratories Limited v. [read post]
24 Nov 2010, 8:22 am by Stefanie Levine
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
24 Nov 2010, 8:22 am by Stefanie Levine
Filed November 19, 2010 by Abbott Diabetes Care Inc. (15) 90/011,346 (electronically filed) - U.S. [read post]
20 Oct 2010, 5:41 am by Joe Consumer
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
20 Oct 2010, 5:41 am by Joe Consumer
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
1 Oct 2010, 5:25 am by Maxwell Kennerly
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]